<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nagral</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sawant</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Malde</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Parikh</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nagral</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Merchant</surname>
    <given-names>R.</given-names>
   </name>
  </person-group> (
  <year>2017</year>). 
  <article-title>Experience with direct acting antivirals (DAA) agents in treatment of chronic hepatitis C virus (HCV) infection in patients of thalassemia major</article-title>. 
  <source>J. Clin. Exp. Hepatol</source>. 
  <volume>7</volume>, 
  <fpage>172</fpage>â€“
  <lpage>178</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.jceh.2017.08.002</pub-id>
  <pub-id pub-id-type="pmid">28970702</pub-id>
 </mixed-citation>
</ref>
